ISSAQUAH, Wash.--(BUSINESS WIRE)-- Spacelabs Healthcare will unveil its new and expanded collection of innovative patient monitoring and connectivity solutions, on May 22-24 at the National Teaching Institute & Critical Care Exposition (NTI 2012) in Orlando, Florida. A perfect blend of technology and design, the Art of Monitoring portfolio now includes:

• qube^TM Inspired by the revolutionary style of XPREZZON^TM, qube breaks with tradition to offer a fresh, new perspective in compact monitoring.
• AriaTele^TM Feature-rich telemetry transmitters delivering high performance and style (Pending 510(k) Not for Sale in USA.)
• ICS Xprezz^TM Mobile app for iPad providing clinicians with up-to-the-minute views of waveform or numeric data in the palms of their hands
• XPREZZON^TM Patient monitoring system that delivers innovative technology and design to shape the new age of care for clinicians and patients alike

This portfolio offers a new perspective in patient monitoring. First and foremost, we are providing clinicians with the patient data they need, at their fingertips in order to increase efficiencies and improve outcomes. Secondly, we are presenting it in such a way that is designed to be familiar and pleasing to caregiver, patient and family, said Nicholas Ong, President of Spacelabs Healthcare.

About Spacelabs Healthcare, Inc.

Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com), a wholly-owned subsidiary of OSI Systems, Inc. (OSIS), is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Companys expectations, goals or intentions about the future, including, but not limited to, statements regarding the performance of the Companys products. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.

Spacelabs.The_Art_of_Monitoring_small
Spacelabs.The_Art_of_Monitoring_med
Spacelabs.The_Art_of_Monitoring_large

Spacelabs Healthcare, Inc.
Glyn Barnes
Mobile: +44 (0)7738 342516
Office: +44 (0)1992 507700
glyn.barnes@spacelabs.com

Source: Spacelabs Healthcare, Inc.

Copyright Business Wire 2012